Search results for: "johnson johnson"

(218 records)

Johnson & Johnson to buy Aragon Pharmaceuticals

Will acquire a late-stage prostate cancer treatment and thereby strengthen its oncology pipeline
You need to be a subscriber to read this article.
Click here to find out more.
Regulatory
Blood cancers – ibrutinib

Blood cancers – ibrutinib

There is a need for new treatment options for patients whose treated chronic lymphocytic leukaemia or other B-cell malignancy has relapsed, or who do not respond to existing...

EU molecule research project makes synthesis simpler

Scientists have developed olefin metathesis reaction process
You need to be a subscriber to read this article.
Click here to find out more.
Research & Development
Fostering the development of innovative medicines

Fostering the development of innovative medicines

Confidence in the pharma sector seems to be picking up, with higher drug approvals in the US, M&A activity increasing and opportunities in emerging markets. However, healthcare...
You need to be a subscriber to read this article.
Click here to find out more.
Research & Development
Drug approvals: more numerous but niche

Drug approvals: more numerous but niche

After many years of low approval rates, in 2012 more than 30 new drugs were approved by the European Medicines Agency. Although many of them were niche products, some were for...

Araxes Pharma enters into cancer drug development pact with Janssen Biotech

To develop therapeutics for the treatment of cancer

EC warns Novartis and Johnson & Johnson

Over Dutch subsidiaries agreement on fentanyl sales

NGM and Janssen to develop diabetes drugs

The two companies sign a worldwide agreement

CEO Alex Gorsky elected chairman of Johnson & Johnson

Bill Weldon to step down after 41-year career at the company

Ten pharmaceutical companies team up to accelerate new medicines development

TransCelerate BioPharma aims to solve common drug development challenges

West signs agreement with Janssen Biotech to develop self-injection technology

System can enable safe, effective and reliable delivery of complex biopharmaceutical medications

Universal flu vaccine takes a step closer

Scientists find a human antibody that offers protection against Type A and B flu strains

IMI launches €223.7m project to combat antibiotic resistance

Academics and five pharma firms will share research data and improve efficiency of clinical trials
You need to be a subscriber to read this article.
Click here to find out more.
Research & Development
2011 nces focus on cancer therapies

2011 nces focus on cancer therapies

The future of the pharma industry increasingly lies in drugs for diseases with smaller patient populations, and those targeted more precisely at specific patient...

Drug companies join forces to end neglected tropical diseases

Will expand drug donation programmes and provide US$785m to support r&d efforts

Janssen Research & Development opens life science innovation centre in San Diego

Will provide lab environment for life science start-ups

Trending Articles

  1. Loftware and RiseNow partner to strengthen supply chain traceability and compliance in healthcare settings The alliance pairs Loftware's SAP-integrated product identification platform with RiseNow's procurement and supply chain advisory services, delivering end-to-end track-and-trace capabilities for regulated industries where audit readiness and patient safety are critical
  2. Carterra and AstraZeneca collaborate on AI-driven drug discovery The collaboration will develop integrated laboratory hardware and software to generate standardised experimental data for lab-in-the-loop biologics discovery
  3. Syntegon launches European Annex 1 compliance roadshow Pharma equipment supplier Syntegon is taking automated contamination control technologies and expert advice directly to manufacturers and CDMOs across Europe, with its Annex 1 Roadshow running until April 2027
  4. Malvern Panalytical acquires Dimer Instruments to expand biopharma analysis The purchase strengthens Malvern Panalytical’s biopharmaceutical characterisation capabilities, building on the development of its high-throughput Zetasizer Core stability screening platform
  5. Corsearch launches AI-powered pharmaceutical naming platform Corsearch Pharma combines AI-driven name generation, trademark screening and regulatory risk assessment in a single workflow to help pharmaceutical companies accelerate drug naming and clearance

You may also like

Manufacturing Company increases its score to 82 out of 100 points, ranking in the top 5% of rated companies and the top 1% for sustainable procurement
Gerresheimer improves EcoVadis rating and retains Gold status

Gerresheimer improves EcoVadis rating and retains Gold status

Read more
Manufacturing Exclusive access to Qurient’s CDK7 inhibitors adds a new linker-payload option for dual-payload ADC development
Lonza expands dual-payload ADC technology offering through Qurient agreement

Lonza expands dual-payload ADC technology offering through Qurient agreement

Read more
Manufacturing Abzena’s Gary Watts explains how early planning, analytical characterisation and manufacturing readiness can help prevent costly delays in preclinical development
Expert shares how to avoid common pitfalls in preclinical development

Expert shares how to avoid common pitfalls in preclinical development

Read more
Rigel Gallegos will lead the development of EyeC’s OEM and system integrator business
EyeC expands OEM growth with new business development manager

EyeC expands OEM growth with new business development manager

Read more
Manufacturing Experienced CRO leader brings deep scientific, commercial and operational expertise to lead the company’s next phase of growth
Concept Life Sciences appoints Dr Adrijana Vinter as Chief Executive Officer

Concept Life Sciences appoints Dr Adrijana Vinter as Chief Executive Officer

Read more
Manufacturing New integrated solutions help pharmaceutical manufacturers and CDMOs increase automation, improve efficiency, and streamline packaging operations
Systech launches new all-in-one pharma packaging and serialisation stations

Systech launches new all-in-one pharma packaging and serialisation stations

Read more
Research & Development The Swedish biotech has voluntarily paused its Phase IIa trial of sevuparin for chronic kidney disease-associated anaemia following a suspected serious adverse reaction,...
Modus Therapeutics pauses Phase II trial after unexpected serious adverse event in patient

Modus Therapeutics pauses Phase II trial after unexpected serious adverse event in patient

Read more
Regulatory The US agency’s SURPASS programme aims to replace sequential Phase I-III trials with continuous adaptive studies, raising questions for clinical supply and manufacturing...
ARPA-H SURPASS programme targets phaseless clinical trials

ARPA-H SURPASS programme targets phaseless clinical trials

Read more